Comparison of Short-Wavelength Reduced-Illuminance and Conventional Autofluorescence Imaging in Stargardt Macular Dystrophy
暂无分享,去创建一个
A. Cideciyan | B. Munoz | S. Sadda | S. West | Y. Wolfson | M. Michaelides | H. Scholl | R. Strauss | A. Jha | Melissa L. Kasilian | Alexander Ho
[1] S. Sadda,et al. COMPARISON OF MANUAL AND SEMIAUTOMATED FUNDUS AUTOFLUORESCENCE ANALYSIS OF MACULAR ATROPHY IN STARGARDT DISEASE PHENOTYPE , 2016, Retina.
[2] J. Sahel,et al. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1. , 2016, Ophthalmology.
[3] Hendrik P N Scholl,et al. Assessment of estimated retinal atrophy progression in Stargardt macular dystrophy using spectral-domain optical coherence tomography , 2015, British Journal of Ophthalmology.
[4] C. Klaver,et al. Causes and consequences of inherited cone disorders , 2014, Progress in Retinal and Eye Research.
[5] K. Tsubota,et al. A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations. , 2013, Investigative ophthalmology & visual science.
[6] R. Molday,et al. ABCA4 is an N-retinylidene-phosphatidylethanolamine and phosphatidylethanolamine importer , 2012, Nature Communications.
[7] R. T. Smith,et al. Quantitative measurements of autofluorescence with the scanning laser ophthalmoscope. , 2011, Investigative ophthalmology & visual science.
[8] Netan Choudhry,et al. Fundus Autofluorescence in Geographic Atrophy: A Review , 2010, Seminars in ophthalmology.
[9] Donald C Hood,et al. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. , 2009, Investigative ophthalmology & visual science.
[10] F. Ferris,et al. Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium. , 2008, Investigative ophthalmology & visual science.
[11] T. Aleman,et al. Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations. , 2007, Journal of the Optical Society of America. A, Optics, image science, and vision.
[12] Alexander Sumaroka,et al. In vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosa. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[13] G. Travis,et al. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] K. Nakanishi,et al. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. , 2000, Investigative ophthalmology & visual science.
[15] J. Lupski,et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophy , 1997, Nature Genetics.
[16] F W Fitzke,et al. Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. , 1995, The British journal of ophthalmology.
[17] C K Dorey,et al. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. , 1995, Investigative ophthalmology & visual science.
[18] M. Boulton,et al. Lipofuscin is a photoinducible free radical generator. , 1993, Journal of photochemistry and photobiology. B, Biology.